S100A8 and non-Hodgkin lymphoma: Based on the latter study, elevated serum S100A8 protein and leucine-rich alpha-2-glycoprotein 1 (LRG1) are promising candidate biomarkers for pediatric NHL, identifying 97% of patients [26].